Predicting how atherosclerosis, osteoporosis or cancer will progress or respond to drugs in individual patients is difficult. In a new study, researchers took another step toward that goal by developing a technique able to predict from a blood sample the amount of cathepsins - protein-degrading enzymes known to accelerate these diseases - a specific person would produce. This patient-specific information may be helpful in developing personalized approaches to treat these tissue-destructive diseases...
More...
More...